Literature DB >> 12581201

Structural diversity in lipopolysaccharide expression in nontypeable Haemophilus influenzae. Identification of L-glycerol-D-manno-heptose in the outer-core region in three clinical isolates.

Martin Månsson1, Derek W Hood, E Richard Moxon, Elke K H Schweda.   

Abstract

Structural elucidation of the lipopolysaccharide (LPS) from three nontypeable Haemophilus influenzae clinical isolates, 1209, 1207 and 1233 was achieved using NMR spectroscopy and ESI-MS on O-deacylated LPS and core oligosaccharide (OS) material as well as ESI-MS(n) on permethylated dephosphorylated OS. It was found that the organisms expressed a tremendous heterogeneous glycoform mixture resulting from the variable length of the OS chains attached to the common structural element of H. influenzae, L-alpha-D-Hepp-(1-->2)-[PEtn-->6]-L-alpha-D-Hepp-(1-->3)-[beta-D-Glcp-(1-->4)]-L-alpha-D-Hepp-(1-->5)-[PPEtn-->4]-alpha-Kdop-(2-->6)-Lipid A. Notably, the O-6 position of the beta-D-Glcp residue could either be occupied by PCho or L-glycero-D-manno-heptose (L,D-Hep), which is a location for L,D-Hep that has not been seen previously in H. influenzae LPS. The outer-core L,D-Hep residue was further chain elongated at the O-6 position by the structural element beta-D-GalpNAc-(1-->3)-alpha-D-Galp-(1-->4)-beta-D-Galp, or sequentially truncated versions thereof. The distal heptose residue in the inner-core was found to be chain elongated at O-2 by the globotetraose unit, beta-D-GalpNAc-(1-->3)-alpha-D-Galp-(1-->4)-beta-D-Galp-(1-->4)-beta-D-Glcp, or sequentially truncated versions thereof. Investigation of LPS from an lpsA mutant of isolate 1233 and a lic1 mutant of isolate 1209 was also performed, which aside from confirming the functions of the gene products, simplified elucidation of the OS extending from the proximal heptose (the lpsA mutant), and showed that the organism exclusively expresses LPS glycoforms comprising the outer-core l,d-Hep residue when PCho is not expressed (the lic1 mutant).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581201     DOI: 10.1046/j.1432-1033.2003.03399.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Biosynthesis of cryptic lipopolysaccharide glycoforms in Haemophilus influenzae involves a mechanism similar to that required for O-antigen synthesis.

Authors:  Derek W Hood; Gaynor Randle; Andrew D Cox; Katherine Makepeace; Jianjun Li; Elke K H Schweda; James C Richards; E Richard Moxon
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

2.  Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum.

Authors:  Alice L Erwin; Simon Allen; Derek K Ho; Paul J Bonthuis; Paul J Bonthius; Justin Jarisch; Kevin L Nelson; David L Tsao; William C T Unrath; Michael E Watson; Bradford W Gibson; Michael A Apicella; Arnold L Smith
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

3.  Elucidation of the monoclonal antibody 5G8-reactive, virulence-associated lipopolysaccharide epitope of Haemophilus influenzae and its role in bacterial resistance to complement-mediated killing.

Authors:  Ruth Griffin; Andrew D Cox; Katherine Makepeace; James C Richards; E Richard Moxon; Derek W Hood
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Heterogeneity in tandem octanucleotides within Haemophilus influenzae lipopolysaccharide biosynthetic gene losA affects serum resistance.

Authors:  Alice L Erwin; Paul J Bonthuis; Jennifer L Geelhood; Kevin L Nelson; Kirk W McCrea; Janet R Gilsdorf; Arnold L Smith
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Application of capillary electrophoresis mass spectrometry and liquid chromatography multiple-step tandem electrospray mass spectrometry to profile glycoform expression during Haemophilus influenzae pathogenesis in the chinchilla model of experimental otitis media.

Authors:  Susanna L Lundström; Jianjun Li; Martin Månsson; Marisol Figueira; Magali Leroy; Richard Goldstein; Derek W Hood; E Richard Moxon; James C Richards; Elke K H Schweda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

6.  Lex2B, a phase-variable glycosyltransferase, adds either a glucose or a galactose to Haemophilus influenzae lipopolysaccharide.

Authors:  M E Deadman; P Hermant; M Engskog; K Makepeace; E R Moxon; E K H Schweda; D W Hood
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

7.  Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins.

Authors:  Shayla West-Barnette; Andrea Rockel; W Edward Swords
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Phosphocholine-Modified Lipooligosaccharides of Haemophilus influenzae Inhibit ATP-Induced IL-1β Release by Pulmonary Epithelial Cells.

Authors:  Katrin Richter; Christian Koch; Alexander Perniss; Philipp M Wolf; Elke K H Schweda; Sven Wichmann; Sigrid Wilker; Ilona Magel; Michael Sander; J Michael McIntosh; Winfried Padberg; Veronika Grau
Journal:  Molecules       Date:  2018-08-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.